Please contact our sales team for your Consulting and Customization queries/concerns at [email protected].
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
The global Inosine Pranobex market is projected to grow from US$ 205.8 million in 2023 to US$ 234.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.2% during the forecast period.
Global Inosine Pranobex key players include Newport Pharmaceuticals, Gedeon Richter, etc. Global top two manufacturers hold a share about 50%.
Europe is the largest market, with a share about 55%, followed by North America and Japan, both have a share about 20 percent.
In terms of product, Tablet is the largest segment, with a share about 70%. And in terms of application, the largest application is Antiviral, followed by Immunomodulation, etc.
Report Includes:
This report presents an overview of global market for Inosine Pranobex, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Inosine Pranobex, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Inosine Pranobex, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Inosine Pranobex sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Inosine Pranobex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Inosine Pranobex sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andrómaco, Yung Shin, Alfasigma S.p.A., Polfarmex and Sanfer, etc.
By Company
- Newport Pharmaceuticals
- Gedeon Richter
- Mochida
- Sanofi
- Andrómaco
- Yung Shin
- Alfasigma S.p.A.
- Polfarmex
- Sanfer
- Meprofarm
- Novell Pharmaceutical
- Aflofarm
Segment by Type
- Tablet
- Syrup
Segment by Application
- Immunomodulation
- Antiviral
- Other
Segment by Region
- US & Canada
- - U.S.
- - Canada
- China
- Asia (excluding China)
- - Japan
- - South Korea
- - China Taiwan
- Southeast Asia
- - India
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Middle East, Africa, Latin America
- - Brazil
- - Mexico
- - Turkey
- - Israel
- - GCC Countries
Chapter Outline
Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Inosine Pranobex in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Inosine Pranobex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inosine Pranobex sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Study Coverage
1.1 Inosine Pranobex Product Introduction
1.2 Market by Type
1.2.1 Global Inosine Pranobex Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablet
1.2.3 Syrup
1.3 Market by Application
1.3.1 Global Inosine Pranobex Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Immunomodulation
1.3.3 Antiviral
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Inosine Pranobex Sales Estimates and Forecasts 2018-2029
2.2 Global Inosine Pranobex Revenue by Region
2.2.1 Global Inosine Pranobex Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Inosine Pranobex Revenue by Region (2018-2023)
2.2.3 Global Inosine Pranobex Revenue by Region (2024-2029)
2.2.4 Global Inosine Pranobex Revenue Market Share by Region (2018-2029)
2.3 Global Inosine Pranobex Sales Estimates and Forecasts 2018-2029
2.4 Global Inosine Pranobex Sales by Region
2.4.1 Global Inosine Pranobex Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Inosine Pranobex Sales by Region (2018-2023)
2.4.3 Global Inosine Pranobex Sales by Region (2024-2029)
2.4.4 Global Inosine Pranobex Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Inosine Pranobex Sales by Manufacturers
3.1.1 Global Inosine Pranobex Sales by Manufacturers (2018-2023)
3.1.2 Global Inosine Pranobex Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inosine Pranobex in 2022
3.2 Global Inosine Pranobex Revenue by Manufacturers
3.2.1 Global Inosine Pranobex Revenue by Manufacturers (2018-2023)
3.2.2 Global Inosine Pranobex Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Inosine Pranobex Revenue in 2022
3.3 Global Key Players of Inosine Pranobex, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Inosine Pranobex Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Inosine Pranobex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Inosine Pranobex, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Inosine Pranobex, Product Offered and Application
3.8 Global Key Manufacturers of Inosine Pranobex, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inosine Pranobex Sales by Type
4.1.1 Global Inosine Pranobex Historical Sales by Type (2018-2023)
4.1.2 Global Inosine Pranobex Forecasted Sales by Type (2024-2029)
4.1.3 Global Inosine Pranobex Sales Market Share by Type (2018-2029)
4.2 Global Inosine Pranobex Revenue by Type
4.2.1 Global Inosine Pranobex Historical Revenue by Type (2018-2023)
4.2.2 Global Inosine Pranobex Forecasted Revenue by Type (2024-2029)
4.2.3 Global Inosine Pranobex Revenue Market Share by Type (2018-2029)
4.3 Global Inosine Pranobex Price by Type
4.3.1 Global Inosine Pranobex Price by Type (2018-2023)
4.3.2 Global Inosine Pranobex Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Inosine Pranobex Sales by Application
5.1.1 Global Inosine Pranobex Historical Sales by Application (2018-2023)
5.1.2 Global Inosine Pranobex Forecasted Sales by Application (2024-2029)
5.1.3 Global Inosine Pranobex Sales Market Share by Application (2018-2029)
5.2 Global Inosine Pranobex Revenue by Application
5.2.1 Global Inosine Pranobex Historical Revenue by Application (2018-2023)
5.2.2 Global Inosine Pranobex Forecasted Revenue by Application (2024-2029)
5.2.3 Global Inosine Pranobex Revenue Market Share by Application (2018-2029)
5.3 Global Inosine Pranobex Price by Application
5.3.1 Global Inosine Pranobex Price by Application (2018-2023)
5.3.2 Global Inosine Pranobex Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Inosine Pranobex Market Size by Type
6.1.1 US & Canada Inosine Pranobex Sales by Type (2018-2029)
6.1.2 US & Canada Inosine Pranobex Revenue by Type (2018-2029)
6.2 US & Canada Inosine Pranobex Market Size by Application
6.2.1 US & Canada Inosine Pranobex Sales by Application (2018-2029)
6.2.2 US & Canada Inosine Pranobex Revenue by Application (2018-2029)
6.3 US & Canada Inosine Pranobex Market Size by Country
6.3.1 US & Canada Inosine Pranobex Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Inosine Pranobex Sales by Country (2018-2029)
6.3.3 US & Canada Inosine Pranobex Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Inosine Pranobex Market Size by Type
7.1.1 Europe Inosine Pranobex Sales by Type (2018-2029)
7.1.2 Europe Inosine Pranobex Revenue by Type (2018-2029)
7.2 Europe Inosine Pranobex Market Size by Application
7.2.1 Europe Inosine Pranobex Sales by Application (2018-2029)
7.2.2 Europe Inosine Pranobex Revenue by Application (2018-2029)
7.3 Europe Inosine Pranobex Market Size by Country
7.3.1 Europe Inosine Pranobex Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Inosine Pranobex Sales by Country (2018-2029)
7.3.3 Europe Inosine Pranobex Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Inosine Pranobex Market Size
8.1.1 China Inosine Pranobex Sales (2018-2029)
8.1.2 China Inosine Pranobex Revenue (2018-2029)
8.2 China Inosine Pranobex Market Size by Application
8.2.1 China Inosine Pranobex Sales by Application (2018-2029)
8.2.2 China Inosine Pranobex Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Inosine Pranobex Market Size by Type
9.1.1 Asia Inosine Pranobex Sales by Type (2018-2029)
9.1.2 Asia Inosine Pranobex Revenue by Type (2018-2029)
9.2 Asia Inosine Pranobex Market Size by Application
9.2.1 Asia Inosine Pranobex Sales by Application (2018-2029)
9.2.2 Asia Inosine Pranobex Revenue by Application (2018-2029)
9.3 Asia Inosine Pranobex Sales by Region
9.3.1 Asia Inosine Pranobex Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Inosine Pranobex Revenue by Region (2018-2029)
9.3.3 Asia Inosine Pranobex Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Inosine Pranobex Market Size by Type
10.1.1 Middle East, Africa and Latin America Inosine Pranobex Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Inosine Pranobex Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Inosine Pranobex Market Size by Application
10.2.1 Middle East, Africa and Latin America Inosine Pranobex Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Inosine Pranobex Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Inosine Pranobex Sales by Country
10.3.1 Middle East, Africa and Latin America Inosine Pranobex Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Inosine Pranobex Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Inosine Pranobex Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Newport Pharmaceuticals
11.1.1 Newport Pharmaceuticals Company Information
11.1.2 Newport Pharmaceuticals Overview
11.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Newport Pharmaceuticals Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Newport Pharmaceuticals Recent Developments
11.2 Gedeon Richter
11.2.1 Gedeon Richter Company Information
11.2.2 Gedeon Richter Overview
11.2.3 Gedeon Richter Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Gedeon Richter Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gedeon Richter Recent Developments
11.3 Mochida
11.3.1 Mochida Company Information
11.3.2 Mochida Overview
11.3.3 Mochida Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Mochida Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mochida Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Sanofi Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Andrómaco
11.5.1 Andrómaco Company Information
11.5.2 Andrómaco Overview
11.5.3 Andrómaco Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Andrómaco Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Andrómaco Recent Developments
11.6 Yung Shin
11.6.1 Yung Shin Company Information
11.6.2 Yung Shin Overview
11.6.3 Yung Shin Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Yung Shin Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Yung Shin Recent Developments
11.7 Alfasigma S.p.A.
11.7.1 Alfasigma S.p.A. Company Information
11.7.2 Alfasigma S.p.A. Overview
11.7.3 Alfasigma S.p.A. Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Alfasigma S.p.A. Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alfasigma S.p.A. Recent Developments
11.8 Polfarmex
11.8.1 Polfarmex Company Information
11.8.2 Polfarmex Overview
11.8.3 Polfarmex Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Polfarmex Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Polfarmex Recent Developments
11.9 Sanfer
11.9.1 Sanfer Company Information
11.9.2 Sanfer Overview
11.9.3 Sanfer Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Sanfer Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanfer Recent Developments
11.10 Meprofarm
11.10.1 Meprofarm Company Information
11.10.2 Meprofarm Overview
11.10.3 Meprofarm Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Meprofarm Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Meprofarm Recent Developments
11.11 Novell Pharmaceutical
11.11.1 Novell Pharmaceutical Company Information
11.11.2 Novell Pharmaceutical Overview
11.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Novell Pharmaceutical Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novell Pharmaceutical Recent Developments
11.12 Aflofarm
11.12.1 Aflofarm Company Information
11.12.2 Aflofarm Overview
11.12.3 Aflofarm Inosine Pranobex Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Aflofarm Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aflofarm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inosine Pranobex Industry Chain Analysis
12.2 Inosine Pranobex Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inosine Pranobex Production Mode & Process
12.4 Inosine Pranobex Sales and Marketing
12.4.1 Inosine Pranobex Sales Channels
12.4.2 Inosine Pranobex Distributors
12.5 Inosine Pranobex Customers
13 Market Dynamics
13.1 Inosine Pranobex Industry Trends
13.2 Inosine Pranobex Market Drivers
13.3 Inosine Pranobex Market Challenges
13.4 Inosine Pranobex Market Restraints
14 Key Findings in The Global Inosine Pranobex Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Inosine Pranobex Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Syrup
Table 4. Global Inosine Pranobex Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Inosine Pranobex Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Inosine Pranobex Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Inosine Pranobex Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Inosine Pranobex Revenue Market Share by Region (2018-2023)
Table 9. Global Inosine Pranobex Revenue Market Share by Region (2024-2029)
Table 10. Global Inosine Pranobex Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Inosine Pranobex Sales by Region (2018-2023) & (K Units)
Table 12. Global Inosine Pranobex Sales by Region (2024-2029) & (K Units)
Table 13. Global Inosine Pranobex Sales Market Share by Region (2018-2023)
Table 14. Global Inosine Pranobex Sales Market Share by Region (2024-2029)
Table 15. Global Inosine Pranobex Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Inosine Pranobex Sales Share by Manufacturers (2018-2023)
Table 17. Global Inosine Pranobex Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Inosine Pranobex Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Inosine Pranobex, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Inosine Pranobex Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Inosine Pranobex Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Inosine Pranobex by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inosine Pranobex as of 2022)
Table 23. Global Key Manufacturers of Inosine Pranobex, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Inosine Pranobex, Product Offered and Application
Table 25. Global Key Manufacturers of Inosine Pranobex, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Inosine Pranobex Sales by Type (2018-2023) & (K Units)
Table 28. Global Inosine Pranobex Sales by Type (2024-2029) & (K Units)
Table 29. Global Inosine Pranobex Sales Share by Type (2018-2023)
Table 30. Global Inosine Pranobex Sales Share by Type (2024-2029)
Table 31. Global Inosine Pranobex Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Inosine Pranobex Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Inosine Pranobex Revenue Share by Type (2018-2023)
Table 34. Global Inosine Pranobex Revenue Share by Type (2024-2029)
Table 35. Inosine Pranobex Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Inosine Pranobex Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Inosine Pranobex Sales by Application (2018-2023) & (K Units)
Table 38. Global Inosine Pranobex Sales by Application (2024-2029) & (K Units)
Table 39. Global Inosine Pranobex Sales Share by Application (2018-2023)
Table 40. Global Inosine Pranobex Sales Share by Application (2024-2029)
Table 41. Global Inosine Pranobex Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Inosine Pranobex Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Inosine Pranobex Revenue Share by Application (2018-2023)
Table 44. Global Inosine Pranobex Revenue Share by Application (2024-2029)
Table 45. Inosine Pranobex Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Inosine Pranobex Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Inosine Pranobex Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Inosine Pranobex Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Inosine Pranobex Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Inosine Pranobex Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Inosine Pranobex Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Inosine Pranobex Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Inosine Pranobex Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Inosine Pranobex Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Inosine Pranobex Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Inosine Pranobex Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Inosine Pranobex Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Inosine Pranobex Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Inosine Pranobex Sales by Country (2024-2029) & (K Units)
Table 60. Europe Inosine Pranobex Sales by Type (2018-2023) & (K Units)
Table 61. Europe Inosine Pranobex Sales by Type (2024-2029) & (K Units)
Table 62. Europe Inosine Pranobex Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Inosine Pranobex Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Inosine Pranobex Sales by Application (2018-2023) & (K Units)
Table 65. Europe Inosine Pranobex Sales by Application (2024-2029) & (K Units)
Table 66. Europe Inosine Pranobex Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Inosine Pranobex Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Inosine Pranobex Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Inosine Pranobex Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Inosine Pranobex Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Inosine Pranobex Sales by Country (2018-2023) & (K Units)
Table 72. Europe Inosine Pranobex Sales by Country (2024-2029) & (K Units)
Table 73. China Inosine Pranobex Sales by Type (2018-2023) & (K Units)
Table 74. China Inosine Pranobex Sales by Type (2024-2029) & (K Units)
Table 75. China Inosine Pranobex Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Inosine Pranobex Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Inosine Pranobex Sales by Application (2018-2023) & (K Units)
Table 78. China Inosine Pranobex Sales by Application (2024-2029) & (K Units)
Table 79. China Inosine Pranobex Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Inosine Pranobex Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Inosine Pranobex Sales by Type (2018-2023) & (K Units)
Table 82. Asia Inosine Pranobex Sales by Type (2024-2029) & (K Units)
Table 83. Asia Inosine Pranobex Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Inosine Pranobex Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Inosine Pranobex Sales by Application (2018-2023) & (K Units)
Table 86. Asia Inosine Pranobex Sales by Application (2024-2029) & (K Units)
Table 87. Asia Inosine Pranobex Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Inosine Pranobex Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Inosine Pranobex Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Inosine Pranobex Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Inosine Pranobex Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Inosine Pranobex Sales by Region (2018-2023) & (K Units)
Table 93. Asia Inosine Pranobex Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Inosine Pranobex Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Inosine Pranobex Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Inosine Pranobex Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Inosine Pranobex Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Inosine Pranobex Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Inosine Pranobex Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Inosine Pranobex Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Inosine Pranobex Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Inosine Pranobex Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Inosine Pranobex Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Inosine Pranobex Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Inosine Pranobex Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Inosine Pranobex Sales by Country (2024-2029) & (K Units)
Table 107. Newport Pharmaceuticals Company Information
Table 108. Newport Pharmaceuticals Description and Major Businesses
Table 109. Newport Pharmaceuticals Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Newport Pharmaceuticals Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Newport Pharmaceuticals Recent Developments
Table 112. Gedeon Richter Company Information
Table 113. Gedeon Richter Description and Major Businesses
Table 114. Gedeon Richter Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Gedeon Richter Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Gedeon Richter Recent Developments
Table 117. Mochida Company Information
Table 118. Mochida Description and Major Businesses
Table 119. Mochida Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Mochida Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Mochida Recent Developments
Table 122. Sanofi Company Information
Table 123. Sanofi Description and Major Businesses
Table 124. Sanofi Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Sanofi Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sanofi Recent Developments
Table 127. Andrómaco Company Information
Table 128. Andrómaco Description and Major Businesses
Table 129. Andrómaco Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Andrómaco Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Andrómaco Recent Developments
Table 132. Yung Shin Company Information
Table 133. Yung Shin Description and Major Businesses
Table 134. Yung Shin Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Yung Shin Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Yung Shin Recent Developments
Table 137. Alfasigma S.p.A. Company Information
Table 138. Alfasigma S.p.A. Description and Major Businesses
Table 139. Alfasigma S.p.A. Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Alfasigma S.p.A. Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Alfasigma S.p.A. Recent Developments
Table 142. Polfarmex Company Information
Table 143. Polfarmex Description and Major Businesses
Table 144. Polfarmex Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Polfarmex Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Polfarmex Recent Developments
Table 147. Sanfer Company Information
Table 148. Sanfer Description and Major Businesses
Table 149. Sanfer Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Sanfer Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Sanfer Recent Developments
Table 152. Meprofarm Company Information
Table 153. Meprofarm Description and Major Businesses
Table 154. Meprofarm Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 155. Meprofarm Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Meprofarm Recent Developments
Table 157. Novell Pharmaceutical Company Information
Table 158. Novell Pharmaceutical Description and Major Businesses
Table 159. Novell Pharmaceutical Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 160. Novell Pharmaceutical Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Novell Pharmaceutical Recent Developments
Table 162. Aflofarm Company Information
Table 163. Aflofarm Description and Major Businesses
Table 164. Aflofarm Inosine Pranobex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 165. Aflofarm Inosine Pranobex Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Aflofarm Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Inosine Pranobex Distributors List
Table 170. Inosine Pranobex Customers List
Table 171. Inosine Pranobex Market Trends
Table 172. Inosine Pranobex Market Drivers
Table 173. Inosine Pranobex Market Challenges
Table 174. Inosine Pranobex Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Inosine Pranobex Product Picture
Figure 2. Global Inosine Pranobex Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Inosine Pranobex Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Syrup Product Picture
Figure 6. Global Inosine Pranobex Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Inosine Pranobex Market Share by Application in 2022 & 2029
Figure 8. Immunomodulation
Figure 9. Antiviral
Figure 10. Other
Figure 11. Inosine Pranobex Report Years Considered
Figure 12. Global Inosine Pranobex Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Inosine Pranobex Revenue 2018-2029 (US$ Million)
Figure 14. Global Inosine Pranobex Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Inosine Pranobex Revenue Market Share by Region (2018-2029)
Figure 16. Global Inosine Pranobex Sales 2018-2029 ((K Units)
Figure 17. Global Inosine Pranobex Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Inosine Pranobex Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Inosine Pranobex Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Inosine Pranobex Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Inosine Pranobex Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Inosine Pranobex Sales YoY (2018-2029) & (K Units)
Figure 23. China Inosine Pranobex Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Inosine Pranobex Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Inosine Pranobex Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Inosine Pranobex Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Inosine Pranobex Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Inosine Pranobex Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Inosine Pranobex in the World: Market Share by Inosine Pranobex Revenue in 2022
Figure 30. Global Inosine Pranobex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Inosine Pranobex Sales Market Share by Type (2018-2029)
Figure 32. Global Inosine Pranobex Revenue Market Share by Type (2018-2029)
Figure 33. Global Inosine Pranobex Sales Market Share by Application (2018-2029)
Figure 34. Global Inosine Pranobex Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Inosine Pranobex Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Inosine Pranobex Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Inosine Pranobex Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Inosine Pranobex Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Inosine Pranobex Revenue Share by Country (2018-2029)
Figure 40. US & Canada Inosine Pranobex Sales Share by Country (2018-2029)
Figure 41. U.S. Inosine Pranobex Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Inosine Pranobex Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Inosine Pranobex Sales Market Share by Type (2018-2029)
Figure 44. Europe Inosine Pranobex Revenue Market Share by Type (2018-2029)
Figure 45. Europe Inosine Pranobex Sales Market Share by Application (2018-2029)
Figure 46. Europe Inosine Pranobex Revenue Market Share by Application (2018-2029)
Figure 47. Europe Inosine Pranobex Revenue Share by Country (2018-2029)
Figure 48. Europe Inosine Pranobex Sales Share by Country (2018-2029)
Figure 49. Germany Inosine Pranobex Revenue (2018-2029) & (US$ Million)
Figure 50. France Inosine Pranobex Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Inosine Pranobex Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Inosine Pranobex Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Inosine Pranobex Revenue (2018-2029) & (US$ Million)
Figure 54. China Inosine Pranobex Sales Market Share by Type (2018-2029)
Figure 55. China Inosine Pra
|
Global Inosine Pranobex Sales Market Report 2023
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. I... |
|
Global Inosine Pranobex Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Inosine Pranobex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze ... |
|
Global Inosine Pranobex Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Inosine Pranobex market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies ... |
|
2023-2031 Report on Global Inosine Pranobex Market by Player, Region, Type, Application and Sales Channel
This report studies the Inosine Pranobex market, covering market size for segment by type (Tablet, Syrup, etc.), by application (Immunomodulation, Antiviral Drug, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Newport Phar... |
|
Global Inosine Pranobex Market Growth 2023-2029
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. I... |
|
Global Inosine Pranobex Market Insights: Impact of COVID-19 and Future Expectations to 2028
The Inosine Pranobex market revenue was 208.76 Million USD in 2022, and will reach 250.3 Million USD in 2028, with a CAGR of 3.07% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of t... |
|
Inosine Pranobex Market, Global Outlook and Forecast 2023-2029
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. I... |
|
Global Inosine Pranobex Market Outlook 2022
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme... |
|
Global Inosine Pranobex Market Insights and Forecast to 2028
Inosine Pranobex market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Inosine Pranobex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental anal... |
|
Inosine Pranobex Market - Global Outlook and Forecast 2022-2028
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. I... |
